Atai Life Sciences N.V.

1.24
-0.12 (-8.82%)
At close: Apr 01, 2025, 3:59 PM
1.26
1.76%
Pre-market: Apr 02, 2025, 07:00 AM EDT

Atai Life Sciences Ratios Statement

Year FY24 FY23 FY22 FY21 FY20 FY19
PE Ratio -1.43 -5.57 -2.93 -9.24 -1.11 -0.57
PEG Ratio -0.01 0.08 -0.3 0.10 -0.00 n/a
PS Ratio 691.60 713.23 1.78K 60.17 n/a n/a
PB Ratio 1.83 0.92 1.59 -3.52 1.25 0.17
P/FCF Ratio -2.58 -2.64 -3.93 -19.04 -5.43 -1.26
P/OCF Ratio -2.58 -2.66 -3.97 -19.38 -5.45 -1.26
OCF/S Ratio -267.65 -267.89 -448.36 -3.1 n/a n/a
Debt / Equity Ratio 0.07 0.08 0.06 -0.00 0.02 0.00
Quick Ratio 3.21 9.22 14.71 17.92 8.06 24.25
Current Ratio 3.21 9.22 14.43 17.92 8.09 24.36
Asset Turnover 0.00 0.00 0.00 0.05 n/a n/a
Interest Coverage -32.87 -47.24 -75.61 n/a n/a n/a
Return on Equity -1.28 -0.17 -0.54 0.38 -1.12 -0.3
Return on Assets -0.94 -0.14 -0.46 -0.32 -0.92 -0.28
Return on Invested Capital -0.73 -0.47 -0.53 -0.34 -1.05 0.03
Dividend Yield n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a
Gross Profit Margin 1.00 1.00 0.28 1.00 n/a n/a
Net Profit Margin -484.64 -128.1 -606.91 -6.51 n/a n/a
Pretax Profit Margin -481.83 -125.11 -580.18 -6.7 n/a n/a
Operating Profit Margin -333.41 -399.59 -621.4 -6.66 n/a n/a
FCF Margin -26.77K -26.98K -45.28K -315.93 n/a n/a
EBITDA Margin -470.16 -115.64 -579.46 -5.9 n/a n/a